What is Xarelto?
Xarelto (rivaroxaban) is a tablet prescribed in dosages of 10, 15 and 20 mg/day. It is used to lower the risk of strokes and blood clots in patients with non-heart valve-related atrial fibrillation (irregular heartbeat). It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to reduce the risk of blood clots in patients who have undergone knee or hip replacement surgery.
The anti-coagulant is manufactured by the Janssen Pharmaceutical Companies of Johnson & Johnson and Bayer HealthCare, which have promoted the drug as a convenient, one-tablet-a-day alternative to warfarin (Coumadin) that does not require routine blood monitoring.
Xarelto Dangers And Side Effects
Like any anti-coagulant, Xarelto carries the risk of excessive bleeding. However, while bleeding involving a drug such as warfarin can be addressed through vitamin K injections that promote blood clotting, there is no way to counteract the Xarelto bleeding risk.
In its May 2014 QuarterWatch Report, the Institute for Safe Medication Practices (ISMP) reported that Xarelto had surpassed another controversial blood-thinning medication, Pradaxa (dabigatran), in the number of adverse event reports received by the U.S. Food and Drug Administration (FDA).
As the ISMP reported, the rise in adverse event reports mirrors the fact that Xarelto prescriptions now nearly double the number of Pradaxa prescriptions. The organization observed that there has been “unexpectedly large numbers of thromboembolic events” in Xarelto patients taking 10 mg doses after surgery.
Number of Xarelto Lawsuits Filed Increases
The litigation involving Xarelto continues to grow as there are now over 400 Xarelto lawsuits filed pending in the multidistrict litigation in U.S. District Court, in the Eastern District of Louisiana as that is where all federal claims have been consolidated.
According to the Judicial Panel on Multidistrict Litigation’s records, the update was issued on April 15, 2015. Our firm is also seeing an increase in the number of cases and questions about Xarelto over the past few months.
Users of Xarelto have suffered serious and dangerous side effects including life-threatening bleeding. Xarelto users who have filed lawsuits were not warned of the alleged bleeding risks or the fact that there is no way to counteract a Xarelto bleeding risk.
Xarelto is a new-generation anticoagulant, manufactured by the Janssen Pharmaceutical Companies of Johnson & Johnson and Bayer HealthCare and was approved by the US Food and Drug Administration in 2011 to lower the risk of strokes and blood clots in patients with non-heart valve-related atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) and to reduce the risk of blood clots in patients who have undergone knee or hip replacement surgery.
For the latest information, please visit www.salvilaw.com/xarelto or if you have any questions related to your Xarelto case, call us at 1-800-Salvi-Law.